2017
DOI: 10.1161/cir.0000000000000523
|View full text |Cite
|
Sign up to set email alerts
|

Methodological Standards for Meta-Analyses and Qualitative Systematic Reviews of Cardiac Prevention and Treatment Studies: A Scientific Statement From the American Heart Association

Abstract: Meta-analyses are becoming increasingly popular, especially in the fields of cardiovascular disease prevention and treatment. They are often considered to be a reliable source of evidence for making healthcare decisions. Unfortunately, problems among meta-analyses such as the misapplication and misinterpretation of statistical methods and tests are long-standing and widespread. The purposes of this statement are to review key steps in the development of a metaanalysis and to provide recommendations that will b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
128
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 198 publications
(129 citation statements)
references
References 103 publications
0
128
0
1
Order By: Relevance
“…Data from this study address controversy on the mPAP level required to capture clinical risk in patients referred for RHC or echocardiography using a meta‐analysis, which is the optimal research tool for determining aggregate risk across study populations 26. We report that mildly elevated PA pressures, estimated by either echocardiography or invasive catheterization, are associated with 19% increased risk of mortality over 5 years.…”
Section: Discussionmentioning
confidence: 99%
“…Data from this study address controversy on the mPAP level required to capture clinical risk in patients referred for RHC or echocardiography using a meta‐analysis, which is the optimal research tool for determining aggregate risk across study populations 26. We report that mildly elevated PA pressures, estimated by either echocardiography or invasive catheterization, are associated with 19% increased risk of mortality over 5 years.…”
Section: Discussionmentioning
confidence: 99%
“…During data extraction, different studies performed with the same participants were identified according to name of the project, main authors, year of publication, study location, recruitment centre of participants, description and characteristics of the RT, and baseline levels of outcomes. Only the most comprehensive or recent article was included in the meta‐analysis, unless different outcomes were reported in those studies …”
Section: Methodsmentioning
confidence: 99%
“…A systematic review and meta-analysis was performed in compliance with the Cochrane Collaboration and Preferred Reporting Items for Systematic Reviews and Meta-Analyses Statement [15]. Metaanalysis was performed using the Review Manager (RevMan) software Heterogeneity between the included trials was assessed using the chi-squared test for heterogeneity and the I 2 measure of inconsistency [17], but the choice between a random/fixed effect model was not determined by the results of statistical tests for heterogeneity, but rather, as recently recommended by a scientific statement of the American heart association [18] by evaluating the functional similarity between the included studies and the goal of estimating a common effect size that will be applicable to similar populations to those included in this meta-analysis. For fixed effects, pooled estimates of odds ratio (OR) with 95% confidence intervals (CI) were calculated using the Mantel Haenszel method.…”
Section: Studies Were Excluded Ifmentioning
confidence: 99%